Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0656
D

Failure to Address Anti-Platelet Therapy in Care Plan

Excelsior, Minnesota Survey Completed on 06-16-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to develop and implement a comprehensive, person-centered care plan for one resident that addressed the use of anti-platelet therapy and associated safety precautions. The resident had a history of transient ischemic attack and cerebral infarction, was moderately cognitively impaired, and required assistance with daily activities. Despite being prescribed clopidogrel bisulfate (Plavix) for myocardial infarction, the resident's care plan did not include interventions or monitoring parameters related to anti-platelet therapy, such as monitoring for signs and symptoms of bleeding or bruising. Interviews with nursing staff confirmed that the care plan lacked necessary identification of interventions and monitoring for the anti-platelet medication, and review of facility policy indicated that care plans should be individualized and comprehensive.

An unhandled error has occurred. Reload 🗙